The observed sex-related differences in the pathophysiology of cardiovascular disease may be driven by androgens, such as testosterone, through the Ang II-ACE-AT1 axis stimulation to induce vasoconstriction, vascular dysfunction, and cardiac dysfunction hypertrophy and fibrosis [46,47]. Here, AGTR1 is linked to cardiovascular disorder.